Patient Data In Drug Reviews Would Be Encouraged In Proposed Amendment To User Fee Bill

Patient experience
FDA may have to disclose how it uses patient experience data in drug reviews • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership